Press Releases
 
Dendritic Cell Cancer Vaccine Market Dynamics, Segments and Supply Demand 2017 - 2025

, 15 June 2019 -- Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These cells have proficiency of capturing and processing tumor antigens, which activates expression of lymphocyte co-stimulatory molecules. Consequently, it results in secretion of cytokines to initiate immune response. In 1868, Paul Langerhans discovered dendritic cells. He thought they were a part of the nervous system cells due to their branched structure. Therefore, their identity was mistaken until the 1970s. In 1973, Zanvil Cohn and Ralph Steinman recognized them as a new type of white blood cells (WBC) with distinctive nature, features, concentration, and function in immunity.

Read Report Overview:
https://www.transparencymarketresearch.com/dendritic-cell-cancer-vaccine-market.html

Cancer is an enormously complex disease and researchers are still trying to understand the variety of factors responsible for its origin, transmission, metastasis, etc. According to report on cancer vaccines by the World Health Organization (WHO), in 2016, an anticipated 1.7 Mn new cancer cases were reported in the U.S. alone. Furthermore, the report mentioned that the annual incidence of cancer, worldwide, is projected to increase to 24 Mn by 2035. Presently, there is significant requirement for advanced and efficient treatments for cancer. Current standard approaches include radiation therapy, chemotherapy, and surgery. However, there are some risks and side effects associated with these methods. Different kinds of cancers have various sources of origin and have unique mechanisms which presents different complications in front of researchers to develop wide-ranging therapeutic treatments. Dendritic cells are adaptable in nature. Therefore, they can be modified depending on the cancer under examination, a dendritic cells vaccine can be formulated based on type of tumor accompanying antibodies. This vaccine can be expressed to target multiple cancers, which makes them effective for multiple objectives. Many of the clinical trials are investigating dendritic cell cancer vaccines which has the ability to help numerous patients. Currently, a steady supply of dendritic cells is necessary to develop novel cancer vaccines. Genetically modified dendritic cell cancer vaccines are grander tools for directing intractable cancers such as brain cancer therapy.

Many studies have shown dendritic cells have the potential ability in combinational therapies to restrict the growth of the cancer. The assured curable effect of therapeutics, which also includes these vaccines, has not been proven; however, they are anticipated to perform far better than its contenders in the same category. The rise in investments in research and development activities, together with positive results in clinical trials, are anticipated to drive the expansion of the market for global dendritic cell cancer vaccine. Others factors fuelling the expansion of this market include the ability of dendritic cells to target multiple cancer antigen capability, rise in geriatric population, and technological advancements. Computer technology is assisting oncologists to plan and run replications on hypothetical vaccines to check their consequences on cellular forms, before going to lab tests and utilizing costly resources.

However, the results of dendritic cell cancer vaccines remain mysterious in clinical trials. More than 70% of these vaccine candidates are currently in clinical trial phases of development. The global dendritic cells vaccines market has accomplished to capture the attention of many strategic investors and stakeholders due to a lucrative development in pipeline. More than USD 1.5 billion has already been invested in this area in the last five years. Oncologists believe that this market is likely to present considerable lucrative opportunities due to existing unmet demand for safe and effective cancer treatments with less side effects and the innate advantages of dendritic cells.

Currently, the three marketed cancer vaccines commercially available in different geographies are Provenge (U.S.), CreaVax-RCC (South Korea), and Tumor Antigen Presenting Cells i.e. TAPCells (Chile). Provenge, is the first marketed dendritic cell vaccine available in the market. They are targeted to treat prostate cancer, metastatic renal cell carcinoma, melanoma, and prostate cancer. In April 2010, the FDA approved the first cancer treatment vaccine. This vaccine, sipuleucel-T (Provenge), is approved for usage in some men with metastatic prostate cancer.

Request Brochure of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24461

Key players operating in this market include 3M Company, Batavia Bioservices, Activartis, Dendreon, Merck KGaA, GlaxoSmithKline plc, Northwest Biotherapeutics, Tella Incorporation, Creagene, and ImmunoCellular Therapeutics.

About us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/



# # #


Submitted by hawer on Saturday, 15 June 2019 at 2:04 AM
Category: Health Care & Medical
 
Related News

Biological Product Manufacturing Market Development Trends, Key Manufacturers and Competitive Analys
Tuesday, 18 Jun 2019

Bioceramics Market Overview with Detailed Analysis, Competitive landscape Forecast to 2024
Tuesday, 18 Jun 2019

Myelofibrosis Market Review with Forecast Research Report 2016 - 2024
Tuesday, 18 Jun 2019

Digital PCR and Quantitative PCR Market Size, Share, Emerging Trends, Analysis and Forecasts to 2024
Tuesday, 18 Jun 2019

Hematological Cancers Market Research and Analyzed Report for 2016 – 2024
Tuesday, 18 Jun 2019

Related Events

ISPP 2019 - 12th International Symposium on Pedriatic Pain
Sunday, 16 Jun 2019

Predictive Analytics World for Healthcare - Las Vegas - June, 2019
Sunday, 16 Jun 2019

XXIV World Congress on Parkinson's Disease and Related Disorders, Montreal
Sunday, 16 Jun 2019

Radiology at Gleneagles, Scotland
Monday, 17 Jun 2019

25th Annual Update and Intensive Review of Internal Medicine, New York 2019
Monday, 17 Jun 2019

Latest News

GDAC 2019 to be held in Dongguan on June 19
Tuesday, 18 Jun 2019

Biological Product Manufacturing Market Development Trends, Key Manufacturers and Competitive Analys
Tuesday, 18 Jun 2019

Bioceramics Market Overview with Detailed Analysis, Competitive landscape Forecast to 2024
Tuesday, 18 Jun 2019

Myelofibrosis Market Review with Forecast Research Report 2016 - 2024
Tuesday, 18 Jun 2019

Digital PCR and Quantitative PCR Market Size, Share, Emerging Trends, Analysis and Forecasts to 2024
Tuesday, 18 Jun 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 18 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • ISPP 2019 - 12th International Symposium on Pedriatic Pain
  • The Perl Conference, Pittsburgh 2019
  • Predictive Analytics World for Business - Las Vegas - June, 2019
  • Deep Learning World Las Vegas 2019
  • Predictive Analytics World for Industry 4.0 - Las Vegas - June, 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.